Suggestions
Meredith Cooper
Program Director
Professional Background
Meredith Cooper is an accomplished Quality Improvement and Project Management professional with a notable emphasis on oncology within a tertiary health system. With extensive experience in implementing and maintaining oncology accreditations, she has played a pivotal role in leading quality initiatives that enhance patient care and outcomes in oncology. Currently, she serves as the Program Director for Hematologic Malignancies and Cellular Therapeutics (HMCT) Research at The University of Kansas Cancer Center, where she oversees groundbreaking research programs and collaborates with multidisciplinary teams to advance the field. Her previous roles include Quality Analysis Coordinator and Research Coordinator at The University of Kansas Cancer Center and Clinical Data Coordinator at Quintiles, where she honed her skills in data analysis and coordination in complex clinical environments.
Meredith’s career trajectory reflects a passion for quality improvement and a commitment to oncology research. As a key player in various initiatives, she continuously strives to enhance operational efficiencies while focusing on patient-centered care. By leveraging her expertise in project management, she has successfully led numerous oncology-specific projects, contributing to advancements in treatment protocols and patient access to cutting-edge therapies.
Education and Achievements
Meredith Cooper earned her Bachelor of Arts (BA) in Psychology from the University of Oklahoma, laying a strong foundation for her later work in healthcare and research. Her educational background in psychology allows her to apply a unique perspective on patient care, understanding the emotional and psychological aspects of cancer treatment and patient experience.
Throughout her career, she has achieved significant milestones, including the development of quality improvement frameworks that resulted in increased accreditation standards for oncology programs. Her dedication to continuous education and professional development is evident through her active participation in industry-leading conferences and workshops focused on oncology, quality improvement, and project management.
Notable Contributions
Meredith Cooper has made substantial contributions to the field of oncology through her various roles. As Program Director at The University of Kansas Cancer Center, she leads initiatives that drive research excellence and improve treatment outcomes for patients with hematologic malignancies. Her earlier experience as a Quality Analysis Coordinator provided her with insights into the intricacies of quality control in oncology services, allowing her to streamline processes and enhance compliance with regulatory standards.
In addition to her work at The University of Kansas Cancer Center, Meredith has also made a mark in clinical research as a Clinical Data Coordinator at Quintiles and a Research Assistant/Coordinator at Duke University Health System. These experiences equipped her with vital analytical skills and a strong understanding of the clinical trial process, further enriching her contributions to oncology research.
Overall, Meredith Cooper is a dedicated professional in the nexus of quality improvement, project management, and oncology research. Her extensive experience, coupled with her educational background, positions her as a leader in the field, driving innovation and quality in cancer care.